A Readomized. Double-blind, Placebo-controlled,Parallel-group Studfy to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patgients Who Have Recently Experienced an Acute Coronary Syndrome

StatusActive
Effective start/end date31/01/1330/01/20

Funding

  • Sanofi Pasteur, Inc.: $189,473.13

Keywords

  • Biotechnology & Drug Development, Cardiovascular Research